To Evaluate the Efficacy and Safety of Afatinib for Advanced ALTRK-negative ESCC
Clinical trial NCT05818982 · UNKNOWN
Trial details
- NCT number
- NCT05818982
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-09
- Primary completion
- 2025-02-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.